FORM 4 [ ] Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).         
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES
                                                                                  
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response...
0.5
                      
Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940
                      
1. Name and Address of Reporting Person * EVANS GARY C 2. Issuer Name and Ticker or Trading Symbol NOVAVAX INC [ NVAX ] 5. Relationship of Reporting Person(s) to Issuer (Check all applicable)__X__ Director                    _____ 10% Owner
_____ Officer (give title below)    _____ Other (specify below)
(Last)         (First)         (Middle)
C/O NOVAVAX, INC., 21 FIRSTFIELD ROAD
3. Date of Earliest Transaction (MM/DD/YYYY)
8/18/2020
(Street)
GAITHERSBURG, MD 20878
(City)       (State)       (Zip)
4. If Amendment, Date Original Filed (MM/DD/YYYY)
 
6. Individual or Joint/Group Filing (Check Applicable Line) _X _ Form filed by One Reporting Person
___ Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1.Title of Security
(Instr. 3)
2. Trans. Date 2A. Deemed Execution Date, if any 3. Trans. Code
(Instr. 8)
4. Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4 and 5)
5. Amount of Securities Beneficially Owned Following Reported Transaction(s)
(Instr. 3 and 4)
6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Stock  8/18/2020    M    1000  A $50  322979  D   
Common Stock  8/18/2020    M    1500  A $36.6  324479  D   
Common Stock  8/18/2020    M    4000  A $27.6  328479  D   
Common Stock  8/18/2020    M    4000  A $27.6  332479  D   
Common Stock  8/18/2020    S    10500  D $150.44 (1) 321979  D   
Common Stock                 8000  I  See Footnote (2)

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivate Security
(Instr. 3)
2. Conversion or Exercise Price of Derivative Security 3. Trans. Date 3A. Deemed Execution Date, if any 4. Trans. Code
(Instr. 8)
5. Number of Derivative Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4 and 5)
6. Date Exercisable and Expiration Date 7. Title and Amount of Securities Underlying Derivative Security
(Instr. 3 and 4)
8. Price of Derivative Security
(Instr. 5)
9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Stock Option (Right to Buy)  $50  8/18/2020    M        1000   9/10/2011  3/10/2021  Common Stock  1000  $0.0  0.0  D   
Stock Option (Right to Buy)  $36.6  8/18/2020    M        1500   9/2/2013  3/1/2023  Common Stock  1500  $0.0  0.0  D   
Stock Option (Right to Buy)  $27.6  8/18/2020    M        4000   3/16/2018  3/16/2027  Common Stock  4000  $0.0  0.0  D   
Stock Option (Right to Buy)  $27.6  8/18/2020    M        4000   12/15/2018  12/15/2027  Common Stock  4000  $0  0  D   

Explanation of Responses:
(1)  The reported price is a weighted average price. These shares were sold in multiple transactions at prices ranging from $150.3125 to $151.06, inclusive. The reporting person undertakes to provide to Novavax, Inc., any security holder of Novavax, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each price within the range set forth in this footnote.
(2)  Includes 4,000 shares owned of record by Gary Evans Custodian for Dustin Evans UTMA/TX and 4,000 shares owned of record by Gary Evans Custodian for Casey Evans UTMA/TX.

Reporting Owners
Reporting Owner Name / Address
Relationships
Director 10% Owner Officer Other
EVANS GARY C
C/O NOVAVAX, INC.
21 FIRSTFIELD ROAD
GAITHERSBURG, MD 20878
X



Signatures
/s/ John A. Herrmann III, Attorney-in-Fact 8/20/2020
**Signature of Reporting Person Date
Novavax (NASDAQ:NVAX)
Historical Stock Chart
From Nov 2020 to Dec 2020 Click Here for more Novavax Charts.
Novavax (NASDAQ:NVAX)
Historical Stock Chart
From Dec 2019 to Dec 2020 Click Here for more Novavax Charts.